NYSE - Nasdaq Real Time Price USD
Smith & Nephew plc (SNN)
28.88
+0.13
+(0.45%)
At close: May 16 at 4:00:02 PM EDT
29.17
+0.29
+(1.00%)
After hours: May 16 at 7:51:20 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 2 | 2 |
| Avg. Estimate | 0 | 0 | 1.99 | 2.28 |
| Low Estimate | 0 | 0 | 1.96 | 2.21 |
| High Estimate | 0 | 0 | 2.02 | 2.35 |
| Year Ago EPS | -- | -- | 1.69 | 1.99 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 17 | 18 |
| Avg. Estimate | 1.52B | 1.51B | 6.11B | 6.41B |
| Low Estimate | 1.51B | 1.5B | 6.06B | 6.3B |
| High Estimate | 1.53B | 1.51B | 6.14B | 6.6B |
| Year Ago Sales | 1.44B | 1.41B | 5.81B | 6.11B |
| Sales Growth (year/est) | 5.60% | 6.79% | 5.08% | 5.06% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 1.99 | 2.28 |
| 7 Days Ago | 0 | 0 | 1.99 | 1.87 |
| 30 Days Ago | 0 | 0 | 1.71 | 1.96 |
| 60 Days Ago | 0 | 0 | 1.71 | 1.87 |
| 90 Days Ago | 0 | 0 | 1.63 | 1.61 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 2 | 2 |
| Up Last 30 Days | -- | -- | 2 | 2 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| SNN | -- | -- | 17.99% | 14.64% |
| S&P 500 | 13.31% | 2.67% | 7.78% | 13.74% |
Upgrades & Downgrades
| Maintains | Canaccord Genuity: Hold to Hold | 5/1/2025 |
| Maintains | Canaccord Genuity: Hold to Hold | 3/17/2025 |
| Downgrade | UBS: Buy to Neutral | 3/12/2025 |
| Maintains | Canaccord Genuity: Hold to Hold | 2/26/2025 |
| Upgrade | UBS: Neutral to Buy | 6/5/2024 |
| Maintains | Bernstein: Outperform to Outperform | 10/4/2023 |
Related Tickers
LIVN LivaNova PLC
44.40
+1.32%
ZBH Zimmer Biomet Holdings, Inc.
96.95
+0.23%
OFIX Orthofix Medical Inc.
12.14
-0.49%
AVNS Avanos Medical, Inc.
13.11
+2.82%
PHG Koninklijke Philips N.V.
24.03
-1.03%
ENOV Enovis Corporation
36.06
+0.92%
ZIMV ZimVie Inc.
9.01
+3.68%
CNMD CONMED Corporation
60.29
+0.99%
TMCI Treace Medical Concepts, Inc.
6.72
-0.44%
IART Integra LifeSciences Holdings Corporation
13.57
+4.30%